Physician
Christopher Brooks Morse, M.D.
According to 2025 Medicare claims, Christopher Morse, M.D. (NPI: 1689940017) practices gynecologist/oncologist in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Allegheny, PA. This provider's primary affiliated billing organization is ALLEGHENY CLINIC (NPI: 1518393164; TIN: 251838458) and primary practice location at 15224-1722. Morse is affiliated with the Physician Partners of Western PA LLC (ACO ID: A3547), participating under the MSSP model.
Morse's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 125 traditional Medicare patients, billed 352 HCPCS/CPT codes, and received $53,781 in Medicare payments. The top billing code was 58571 (Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less). Part D data shows 108 prescription claims across 28 beneficiaries totaling $154,920 in drug costs, led by Prochlorperazine Maleate (Prochlorperazine Maleate). Open Payments data shows 2 records totaling $261. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $5,172 and ending at $154,920. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.